CVRF
  • Login
  • Register
  • CVRF's Meetings
    TCTAP AP VALVES & SH COMPLEX PCI

SummitMD SummitMD

TCTAP 2023
  • Home
  • News
    • SummitMD News
    • Conference News
      • TCTAP
      • AP VALVES & SH
      • COMPLEX PCI
      • ACT PROGRAM
  • Videos
    • TCTAP
    • AP VALVES & SH
    • COMPLEX PCI
    • ACT PROGRAM
  • Slides
    • Coronary
    • Endovascular
    • Structural Heart Disease
    • Valve
    • Imaging & Physiology
    • Pharmacology
  • Book
  • Conferences
    • TCTAP
    • AP VALVES & STRUCTURAL HEART
    • COMPLEX PCI
  • About CVRF
    • Mission
    • Board Members
    • R&D Divisions
      • Clinical Research Coordinating Center
      • Translational Research Center
      • Research Activity
      • Paper Publication
    • Education
      • ACT Program
      • Website

Presenter's Information

  • Home
  • Slides

Byoung Kwon Lee, MD

Country Korea (Republic of)
Specialty Interventional Cardiologist
  • Slide Presentations
  1. Weighing the Benefit of High Intensity Statin Treatment
  2. [TCTAP A-001] Outcomes of 6 Months Versus 12 Months Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Biolimus or Durable Polymer Zotarolimus-Eluting Stents: OPTIMA-C Study and Optical Coherence Tomography Sub-Study
  3. [TCTAP A-070] One-year Clinical, Angiographic, and Optical Coherence Tomography Outcomes of 2nd Generation Drug Eluting Stents 6 Months Dual Antiplatelet Therapy Between Biodegradable and Durable Polymer Stent
  4. 6-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of 2nd Generation DES with Biolimus Versus Zotarolimus: Prospective, Randomized, Multicenter Trial
Conference Slides
  • TCTAP
  • AP VALVES & SH
  • COMPLEX PCI
Category

Coronary

  • Left Main
  • Bifurcation
  • CTO
  • Long Lesion
  • Ostial
  • In-stent Restenosis
  • Others

Endovascular

  • Carotid
  • Peripheral Disease
    • SFA
    • BTK
    • Iliac
    • Poplitial
    • Subclavian
  • Abdominal Aorta
  • Renal
  • Others

Structural Heart Disease

  • Congenital Heart Disease
  • HOCM
  • Others

Valve

  • TAVR
  • Others

Imaging & Physiology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

Pharmacology

  • Antiplatelet
  • Anticoagulant
  • Lipid and Inflammation
  • Others

  • Upcoming Events
  • 28th
    TCTAP 2023
    May 6-9, 2023
    Grand Walkerhill Seoul, Korea
  • 12th
    AP VALVES & SH 2023
    August 10-11, 2023
    Grand Walkerhill Seoul, Korea
  • 8th
    COMPLEX PCI 2023
    November 23-24, 2023
    Grand Walkerhill Seoul, Korea
CVRF
CardioVascular Research Foundation
Àç´Ü¹ýÀÎ ½ÉÀåÇ÷°ü¿¬±¸Àç´Ü
2F Asan Institute for Education & Research
88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul 05505, Korea
´ëÇ¥ÀÚ: ¹Ú½ÂÁ¤ | ÀüÈ­¹øÈ£: 02-3010-4720
»ç¾÷ÀÚµî·Ï¹øÈ£: 215-82-06387

Privacy Policy

The Latest News
  • Extended BEST trial offers insight into murky dispute over optimal long-term revasc strategy in MVCAD
    23-01-06
  • TAVI noninferior to surgery for elderly, severe AS patients at moderate operative risk: UK TAVI
    22-10-14
  • [DOWNLOAD FREE EBOOK] Technical Forum A to Z: Complex Coronary Intervention - 3rd Edition
    22-10-7
Porto Website Template

Copyright 2002. All Rights Reserved.